Weight Gain
Hormonal weight gain — especially visceral fat — is one of the most common midlife complaints. We cover GLP-1 medications, HRT effects on body composition, and which providers treat this clinically (not cosmetically).
Articles
13 articles in this topic.
Menopause Weight Gain: Evidence-Based Management Guide for Midlife Women
Why menopause weight gain happens, what the research shows about visceral fat redistribution, and the evidence behind nutrition, strength training, HRT, and pharmacotherapy options women discuss with clinicians.
GLP-1 and Menopause Weight Loss: What the Research Shows in 2026
How GLP-1 medications like semaglutide and tirzepatide perform for midlife weight gain — clinical data, side effects, drug interactions with HRT, and what to discuss with a clinician.
Semaglutide Side Effects in Women: A Complete 2026 Guide
A clinician-reviewed look at semaglutide side effects women report most often — from nausea and constipation to menstrual shifts, hair shedding, and oral contraceptive interactions — plus what the trial data and FDA labels actually say.
Tirzepatide Side Effects in Women: What Research Shows
Tirzepatide side effects in women span from common GI symptoms (nausea in 28-44%) to less-discussed effects on menstrual cycles, hormonal contraception, and bone health. Here's what peer-reviewed evidence shows.
GLP-1 medications for perimenopausal weight gain
Perimenopausal weight gain has a metabolic basis that calorie restriction often can't address. GLP-1 medications target the underlying insulin resistance directly.
How insurance covers GLP-1 for women in 2026
Coverage policies fluctuated dramatically in 2024-2025. We map current major payer rules for Wegovy, Zepbound, and PA requirements.
What happens when you stop taking GLP-1?
STEP-4 trial showed two-thirds of weight regained within a year of stopping semaglutide. Maintenance dosing and lifestyle integration matter more than starting dose.
Which is better для women: semaglutide or tirzepatide?
Head-to-head trial data shows tirzepatide drives ~5% greater weight loss. Both work in women but GI tolerance and dose escalation profiles differ.
Compounded GLP-1 safety: what the FDA shortage list change means
When semaglutide left FDA shortage list in 2024, compounded versions became legally restricted. Pricing, access, and clinical implications.
Sarcopenia: the muscle loss problem behind menopausal weight gain
Women lose 3-8% muscle per decade after 30, accelerating in menopause. Without resistance training, weight loss diets can worsen the underlying problem.
Why do I gain weight after menopause?
Estrogen decline does shift fat distribution к visceral but does not directly cause weight gain. Sleep, NEAT, and muscle loss are bigger drivers.
Should you start GLP-1 after menopause?
GLP-1 medications are FDA-approved without age cap but bone density loss, muscle wasting, and gallstone risk get heavier consideration in postmenopausal patients.
Does HRT help with menopausal weight gain?
HRT does not directly cause weight loss but can shift fat distribution — reducing visceral fat. Combined with GLP-1, the effect is stronger.
Other topics
Hot Flashes
Sudden heat sensations during perimenopause and menopause — causes, treatments, and providers.
Brain Fog
Memory, focus, and word-finding difficulty linked to hormone fluctuation — what helps.
Sleep
Hormonal sleep disturbances — night sweats, insomnia, early waking — and treatments.
Mood
Anxiety, depression, and irritability tied to hormonal shifts — clinical perspectives.
Libido
Low libido and vaginal dryness — hormonal, behavioral, and pharmacological options.
Joint Pain
Estrogen decline and joint stiffness — emerging research and treatment options.
Hormonal Acne
Adult acne tied to androgen imbalance — clinical options including spironolactone.